Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease.

Riccardo Di Domenicantonio,Francesco Trotta,Silvia Cascini,Nera Agabiti,Anna Kohn,Antonio Gasbarrini,Marina Davoli,Antonio Addis

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY（2018）

引用 17|浏览8

暂无评分

摘要

In our population-based cohort study, effectiveness and safety data in new users of ADA or IFX with CD or UC were comparable for the outcomes we tested.

查看译文

关键词

biologics,inflammatory bowel disease,real-world effectiveness

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要